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Purpose: To present refractive outcomes from consecutive cases with the Alcon Wavelight®
EX500 excimer laser using photorefractive keratectomy (PRK) in patients with high myopia.
Methods: A retrospective chart review of consecutive cases of high myopic eyes ($6.0
Diopters [D]) undergoing PRK with the Alcon Wavelight EX500 excimer laser (Alcon Laboratories, Fort Worth, TX, USA) was done. Moderately high myopic eyes (6.0 to ,8.0 D [6 D])
were compared with high myopic eyes (8.0 D or greater [8 D]). Outcomes measured included
pre- and postoperative refractive error, uncorrected distance visual acuity (UDVA), corrected
distance visual acuity, spherical equivalent correction (SEQ), haze incidence, and intraocular
pressure (IOP).
Results: One hundred eighteen eyes of 63 patients were evaluated, with 59 eyes having
12 months of follow-up. Thirty-one eyes of 19 patients had 8.0 D or more of myopia. Twelvemonth average LogMAR UDVA was −0.06 (20/17) for the 6 D group and −0.08 (20/16) for the
8 D group. Average 12-month SEQ was −0.18 D and preoperatively was −7.52 D for the 6 D
group and −0.09 and −9.02 in the 8 D group. Sixty-five eyes (86%) and 24 eyes (96%) had an
SEQ within 0.50 D of emmetropia at 3 months in the 6 and 8 D groups, respectively. One eye
had visually significant haze developed at 8 months. Three eyes had IOP elevation that resolved
with addition of short-term topical IOP-lowering medication.
Conclusion: High myopic PRK with the Alcon Wavelight EX500 excimer laser yields excellent refractive outcomes with a low incidence of complications.
Keywords: high myopia, PRK, wavefront-optimized, refractive surgery
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Photorefractive keratectomy (PRK) has increased in popularity over the last decade
as it has been recognized that a wider range of corrections can be treated when compared to LASIK.1 Still, many USA surgeons shy away from PRK, particularly in high
myopia, because of concerns about slow recovery, inconvenience, risk of haze, more
postoperative visits, and longer postoperative medication regimen. Despite slower
recovery, PRK for high myopia has structural and mechanical advantages as compared
to LASIK. Advantages include greater residual stromal bed and, therefore, less risk of
ectasia and more reserve tissue for enhancement surgery if needed. Avoidance of early
or late flap complications, although rare with femtosecond laser, is another desirable
advantage of PRK. The newest generation 500 Hz high-frequency excimer laser, the
Alcon Wavelight® EX500 (Alcon Laboratories, Fort Worth, TX, USA), has been shown
to safely and effectively treat high myopia with LASIK.2 Before obtaining this laser,
we would preferentially recommended LASIK or phakic intraocular lenses (PIOLs) to
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highly myopic patients. Our excellent LASIK outcomes with
the Wavelight EX500 caused us to reevaluate the success of
high myopic PRK and offer this to appropriately screened
patients. Herein, we compare outcomes with the Wavelight
EX500 excimer laser for moderately high myopic eyes with
6.0 D of myopia, but ,8.0 D of myopia (6 D) to a subset of
eyes with myopia of 8.0 D or more (8 D).

Methods
The University of Utah Institutional Review Board approved
the study and it was conducted in accordance with the tenets
of the Declaration of Helsinki. All patients were provided
with written informed consent. Eyes undergoing PRK with
6.0 D or greater of myopic spherical equivalent (SEQ)
were included in the study for distance correction. A subset
analysis of eyes with 8.0 D or more of myopia was performed.
Patients underwent a standard refractive screening examination with 1 surgeon (MDM). Patients with a history of prior
refractive surgery, keratoconus, form-fruste keratoconus,
and an ablation that would leave ,300 microns of residual
stromal bed (RSB) were excluded.
Corneal epithelium was gently debrided after exposure
to ethanol 20% in balanced salt solution for 35–40 seconds
placed in an 8.0 mm well. Laser ablation was performed
using the wavefront-optimized Alcon Allegretto Wavelight
EX500 excimer laser according to the surgeon-optimized
nomogram.3 Mitomycin C 0.02% (MMC) was used in all
eyes because laser ablation depth was .60 microns, with
application time being from 12 to 20 seconds based on the
surgeon’s preference. Average MMC application time was
12.8±2.42 and 16.4±3.03 seconds in the 6 and the 8 D groups,
respectively. Immediately after MMC, the ocular surface was
rinsed with chilled saline for 30 seconds. One drop of prednisolone acetate 1%, a topical fluoroquinolone, and a topical
nonsteroidal anti-inflammatory drug were instilled and then
a soft bandage contact lens was placed over the eye.

Postoperatively patients used prednisolone acetate 1%
suspension in the operative eye, starting at a frequency of
4 times per day for the first week, then 2 times per day for
3 weeks, and subsequently switched to fluorometholone 0.1%
suspension. Fluorometholone was used 3 times per day for
1 month, then 2 times per day for 1 month, and then stopped.
The primary outcome measure was uncorrected distance visual acuity (UDVA). Secondary outcomes included
intraocular pressure (IOP), corrected distance visual acuity
(CDVA), manifest refraction SEQ, time of MMC application,
and incidence and grade of postoperative corneal haze, based
on the Fantes scale.4 Significant IOP elevation was defined
as $10 mmHg above baseline, or any IOP over 21 mmHg.
Standard statistics were calculated and used to describe
the treatment groups in terms of all study variables including
UDVA, CDVA, manifest refraction, presence or absence
and degree of postoperative corneal haze, and incidence
of other postoperative complications. A P-value of 0.05 or
less was considered statistically significant. Data analysis
was performed using Microsoft Excel (Microsoft Corp,
Redmond, WA, USA).

Results
Sixty-three patients were included in the study. Thirtysix patients (57%) were female and 27 (42%) were male.
The average age was 32.7±7.76 (range 21–53). Six-month
follow-up data were recorded on 83 eyes of 43 patients and
12-month follow-up was obtained on 59 eyes of 32 patients.
Demographic and preoperative parameters of patients in both
the 6 and 8 D groups are compared in Table 1.
Average 6-month and 12-month UDVA values for both
groups are shown in Figures 1 and 2, respectively. Average
LogMAR UDVA at 6 months was −0.07 (20/17) in the 6 D
group and −0.08 (20/16) in the 8 D group. UDVA was 20/20
or better in 52 eyes (85%) in the 6 D group and 20 eyes (91%)
in the 8 D group at 6 months (P=0.14). At 12 months, 40 eyes

Table 1 Preoperative comparison of eyes in both groups
Age
Female/male
Mean LogMAR CDVA
CDVA (20/x)
Spherical equivalent (D)
Sphere (D)
Cylinder (D)

Eyes $6 D ,8 D (n=87)

Eyes $8 D (n=31)

P-value

32.7±7.76 (21–53)
26 (52%)/24 (48%)
−0.07±0.07 (−0.125 to 0)
17.0±2.46 (15 to 20)
−6.91±0.58 (−7.875 to −6)
−7.32±0.75 (−8.75 to −6.25)
0.48±0.29 (0 to 3.00)

32.2±6.64 (23–48)
15 (79%)/4 (21%)
−0.06±0.06 (−0.125 to 0)
17.4±2.49 (15 to 20)
−9.02±0.73 (−10.5 to −8.00)
−9.51±0.96 (−11.75 to −8.25)
0.98±0.89 (0 to 2.50)

0.720
0.471
0.420
,0.001
,0.001
0.901

Note: Values represented as mean ± SD (range).
Abbreviations: CDVA, corrected distance visual acuity; D, diopters; LogMAR, logarithm of the minimum angle of resolution; $6 D ,8 D, more than or equal to 6 D but
less than 8 D, 8 D.
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Figure 1 Six-month postoperative UDVA versus preoperative CDVA.
Abbreviations: CDVA, corrected distance visual acuity; UDVA, uncorrected distance visual acuity; postop, postoperative; preop, preoperative.

(93%) and 16 eyes (100%) had UDVA of 20/20 or better in
the 6 and 8 D groups, respectively (P=0.36). Twelve-month
average LogMAR UDVA was −0.06 (20/17) for the 6 D
group and −0.08 (20/16) for the 8 D group.
Thirty-seven eyes (61%) had no change in CDVA after
PRK at 6 months, whereas 19 eyes (31%) gained 1 line of
CDVA in the 6 D group. Seven eyes (32%) had no change in
CDVA and 14 eyes (64%) gained 1 line of CDVA 6 months
after PRK in the 8 D group. Five eyes (8%) and 1 eye (5%)
lost 1 line of CDVA in the 6 and 8 D groups, respectively
(Figure 3). Figure 4 shows safety outcomes at 12 months. In
the 8 D group, 6 eyes (38%) had no change in CDVA, 8 eyes
(50%) gained 1 line, and 2 eyes (12%) lost 1 line of CDVA.
In the 6 D group, 24 eyes (56%), 14 eyes (33%), and 5 eyes
(12%) had no change in CDVA, gained 1 line, or lost 1 line
of CDVA, respectively.
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Postoperative spherical equivalent refraction (Figure 5)
showed that 51 eyes (84%) and 20 eyes (91%) were within
0.50 D of emmetropia at 6 months in the 6 and 8 D groups.
Fifty-nine eyes (97%) and 22 eyes (100%) were within 1 D
of emmetropia in the 6 and 8 D groups, respectively. At
12 months, 37 eyes (86%) were within 0.5 D of emmetropia
in the 6 D group, and 16 eyes (100%) in the 8 D group were
within the same range (Figure 6).
Figure 7 shows the predictability of PRK corrections
in both groups at 12 months. Three eyes (5%) were overcorrected by 0.50 D. Ten eyes (17%) were undercorrected
by 0.50 D, with 2 eyes (3%) undercorrected by −1.00 D.
All eyes over- or undercorrected by 0.50 D or more were
in the 6 D group. Fifty-two eyes (88%) had 0.25 D or less
of astigmatism at 12 months (Figure 8). One eye (2%)
had 1.25 D of astigmatism at 12 months. Figure 9 shows
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Figure 2 Twelve-month postoperative UDVA versus preoperative CDVA.
Abbreviations: CDVA, corrected distance visual acuity; UDVA, uncorrected distance visual acuity; postop, postoperative; preop, preoperative.
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Figure 3 Percentage of eyes at 6 months postoperatively that lost or gained lines of Snellen corrected distance visual acuity (CDVA).
Abbreviation: postop, postoperative.
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Figure 4 Percentage of eyes at 12 months postoperatively that lost or gained lines of Snellen CDVA.
Abbreviation: CDVA, corrected distance visual acuity; postop, postoperative.
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Figure 5 Six-month postoperative spherical equivalent refractive accuracy.
Abbreviation: postop, postoperative.
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Figure 6 Twelve-month postoperative spherical equivalent refractive accuracy.
Abbreviation: postop, postoperative.

refractive stability of corrections. Only 4% of eyes had
a change in SEQ of 0.50 D or more from 3 to 12 months
postoperatively.
Four eyes with ,8 D of myopia had visually insignificant
trace to 1+ haze at the 1-month visit, with one of these eyes
having persistent trace haze at 3 months with an UCVA of
20/15. One eye developed late haze at 8 months with loss
of 1 line of CDVA.

Three eyes of 2 patients had a significant IOP elevation
during the first 3 postoperative months. IOP returned to
baseline in both cases when the topical corticosteroid (fluorometholone 0.1%) was stopped.

Discussion
Our analysis of 12-month outcomes of high myopic PRK with
the Wavelight EX500 excimer laser shows the procedure to
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Figure 7 Twelve-month postoperative predictability of SE with achieved SE (y-axis) and attempted SE (x-axis).
Abbreviation: SE, spherical equivalent refraction; postop, postoperative.
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Figure 8 Preoperative and 12-month postoperative refractive astigmatism with percentage of eyes (y-axis) versus refractive astigmatism (diopters [D]) on the x-axis.
Abbreviation: postop, postoperative; preop, preoperative.

result in excellent UDVA and a low rate of complications.
Kanellopoulos et al previously reported successful outcomes with the same excimer laser in cases of high myopic
LASIK.2 Our visual acuity outcomes are comparable to this
study. With low rates of postoperative haze, we prefer PRK
in cases of high myopia. Higher regression rates with high
myopic corrections have been documented previously and
PRK leaves more residual stromal bed in case an enhancement surgery is indicated.5 PRK also negates concerns of
LASIK flap complications and leaves more of the stronger
anterior stroma intact. It has been suggested that the risk for
ectasia may be lower with PRK.1 In cases of asymmetric

inferior steepening with normal appearing posterior corneal
elevation, we prefer PRK over LASIK.
The literature is mixed on whether LASIK or PRK
results in more postoperative dry eye. Bower et al analyzed
143 patients before and after LASIK and PRK.6 They found
that 5% of PRK and 0.8% of LASIK eyes developed chronic
dry eye 12 months after treatment. Alternatively, other studies
have concluded that LASIK is associated with neurotrophic
epitheliopathy7 and higher myopic ablations have been
shown to result in higher rates of dry eye after LASIK.8 In
comparison to PRK, LASIK has been shown to decrease tear
secretion to a greater degree.9 Due to our practice location
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Figure 9 Stability of spherical equivalent refraction in diopters (D) at 1, 3, 6, and 12 months.
Abbreviation: postop, postoperative.

1046

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Clinical Ophthalmology 2018:12

Clinical Ophthalmology downloaded from https://www.dovepress.com/ by 73.194.230.227 on 30-Apr-2020
For personal use only.

Dovepress

in the arid western USA, we have observed a high incidence
of dry eye in our screened refractive surgery candidates
and more postoperative dry eye in our LASIK-treated eyes.
Theoretically, this may be supported by the greater number
of corneal nerves transected by a LASIK flap followed by
ablation. If patients have preoperative dry eye signs and
symptoms we tend to recommend PRK to help mitigate
postoperative dry eye complications based on our personal
experience. Others may be doing the same, and this may
result in a bias confounding retrospective studies evaluating
dry eye after LASIK and PRK.
Haze was uncommon in our study population with 5 eyes
(4%) developing haze. Previous studies have reported the
incidence of haze to be up to 20% after PRK, with visually
significant haze in around 2% of eyes.10–12 Sia et al have
shown that application of MMC following high myopic PRK
leads to low rates of haze formation.11 Only 1 eye (0.8%)
developed visually significant haze. The visually significant
haze developed around 8 months after surgery. Late haze has
been reported as a very rare complication, especially when
using adjunctive MMC, which the affected eye received.13
There is also a correlation with higher depth of ablation and
haze development.14 Our PRK patients undergo a 3-month
steroid taper and this has been successful in preventing haze
formation.15 We believe that a slow steroid taper and mitomycin application are especially important in high myopes
based on their increased risk for haze formation.
The group of eyes with 8 D or more of myopia had
particularly good outcomes with 100% of the eyes being
within 0.5 D of emmetropia 12 months after surgery. Our
criteria for treating these highly myopic eyes was very stringent and may have led to selecting eyes that were prone to
better outcomes. Less ideal candidates were encouraged to
consider PIOL as a vision correction option. The safety of
conventional PRK in high myopia has been demonstrated
previously.11 Wavefront-optimized treatments induce less
higher-order aberrations and lead to better quality vision,
but require more tissue per diopter of correction.16,17 The
Wavelight EX500 is FDA-approved for higher myopic ablations than any other wavefront excimer laser in the USA,
allowing a higher range of corrections to be safely treated
with this excimer technology. Study of long-term follow-up
in this group is warranted as these eyes are known to have
more myopic regression.
PRK has limitations. We try to avoid overflattening
corneas, even with wavefront-optimized ablation patterns.
Ectasia still may be a risk and higher-risk patients may be

Clinical Ophthalmology 2018:12
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selected for PRK. Extreme vigilance for risk factors is of
paramount importance in high myopes as there is little margin
for error. Compliance with postoperative steroid regimens
is important in prevention of haze. Corticosteroid eye drops
cause elevated IOP in some patients. There is some unknown
risk with MMC long-term. Patient expectations must be
managed appropriately as the recovery after PRK is much
longer than that of LASIK. We did not measure contrast
sensitivity or perform formal testing of night vision side
effects in this study population. Further study of subjective
symptoms after high myopic PRK is warranted.
Our study is limited by its retrospective nature, small
proportion of patients with 12-month outcomes, and lack of
systematic symptom analysis. Prospective, long-term studies
of high myopic PRK patients along with a study of post-PRK
symptoms would be beneficial.
PRK is effective in reducing spectacle dependence in high
myopes with low complication rates. Eyes with normal structural parameters can be safely treated with PRK while mitigating the risks of LASIK because of higher residual stromal
bed per correction and more accurately correct astigmatism
than currently available PIOLs. Appropriate candidates with
6–11 D of myopia can be offered PRK as an excellent alternative to LASIK or PIOL for surgical vision correction.
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Laser in situ keratomileusis application for myopia over minus 14 diopter
with long-term follow-up. Int Ophthalmol. 2012;32(5):435–441.

submit your manuscript | www.dovepress.com

Dovepress

Powered by TCPDF (www.tcpdf.org)

1047

Dovepress

Clinical Ophthalmology downloaded from https://www.dovepress.com/ by 73.194.230.227 on 30-Apr-2020
For personal use only.

Mifflin et al
6. Bower KS, Sia RK, Ryan DS, Mines MJ, Dartt DA. Chronic dry eye
in photorefractive keratectomy and laser in situ keratomileusis: manifestations, incidence, and predictive factors. J Cataract Refract Surg.
2015;41(12):2624–2634.
7. Ambrósio R Jr, Tervo T, Wilson SE. LASIK-associated dry eye and
neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg. 2008;24(4):396–407.
8. De Paiva CS, Chen Z, Koch DD, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol.
2006;141(3):438–445.
9. Lee JB, Ryu CH, Kim J, Kim EK, Kim HB. Comparison of tear secretion
and tear film instability after photorefractive keratectomy and laser in
situ keratomileusis. J Cataract Refract Surg. 2000;26(9):1326–1331.
10. Parekh P, Davis EA. Prevention and treatment of haze in refractive
surgery. Int Ophthalmol Clin. 2008;48(1):29–40.
11. Sia RK, Ryan DS, Edwards JD, Stutzman RD, Bower KS. The US. Army
Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK
in moderate to high myopia. J Refract Surg. 2014;30(4):256–264.
12. Ang BC, Foo RC, Lim EW, et al. Risk factors for early-onset corneal
haze after photorefractive keratectomy in an Asian population: outcomes from the Singapore Armed Forces Corneal Refractive Surgery
Programme 2006 to 2013. J Cataract Refract Surg. 2016;42(5):
710–716.

Clinical Ophthalmology

Publish your work in this journal
Clinical Ophthalmology is an international, peer-reviewed journal
covering all subspecialties within ophthalmology. Key topics include:
Optometry; Visual science; Pharmacology and drug therapy in eye
diseases; Basic Sciences; Primary and Secondary eye care; Patient
Safety and Quality of Care Improvements. This journal is indexed on

13. Qazi, MA, Johnson, TW, Pepose, JS. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy
with prophylactic intraoperative mitomycin-C; case report and literature
review. J Cataract Refract Surg. 2006;32(9):1573–1578.
14. Kuo IC, Lee SM, Hwang DG. Late-onset corneal haze and myopic
regression after photorefractive keratectomy (PRK). Cornea. 2004;23(4):
350–355.
15. Mifflin MD, Leishman LL, Christiansen SM, Sikder S, Hsu M,
Moshirfar M. Use of loteprednol for routine prophylaxis after photorefractive keratectomy. Clin Ophthalmol. 2012;6:653–659.
16. El Awady HE, Ghanem AA, Saleh SM. Wavefront-optimized ablation
versus topography-guided customized ablation in myopic LASIK:
comparative study of higher order aberrations. Ophthalmic Surg Lasers
Imaging. 2011;42(4):314–320.
17. Moshirfar M, Churgin DS, Betts BS, et al. Prospective, randomized,
fellow eye comparison of WaveLight Allegretto Wave Eye-Q versus
VISX CustomVue™ STAR S4 IR™ in photorefractive keratectomy:
analysis of visual outcomes and higher-order aberrations. Clin
Ophthalmol. 2011;5:1185–1193.

Dovepress
PubMed Central and CAS, and is the official journal of The Society of
Clinical Ophthalmology (SCO). The manuscript management system
is completely online and includes a very quick and fair peer-review
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.

Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal

1048

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Clinical Ophthalmology 2018:12

